A Clinical Assessment of the Hemacopolymer Daily Disposable Limbal Ring Soft Contact Lens
NCT ID: NCT01965262
Last Updated: 2017-03-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2014-04-30
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Somofilcon A Daily Disposable Test Contact Lens and Somofilcon A Daily Disposable Control Contact Lens
NCT03372551
Evaluation of The Clinical Acceptance of Soft Contact Lenses for Myopia Control
NCT04709237
Clinical Evaluation of Daily Disposable Contact Lenses
NCT02097030
Clinical Performance of a New Daily Disposable Contact Lens Worn in an Established Contact Lens Wearing Population
NCT00708643
Multi-Center Clinical Evaluation of Two Reusable Soft Contact Lenses
NCT02542072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hema-copolymer Lens
Participants were randomized to wear the Hema-copolymer lens pair for one week during the cross over study.
Hema-copolymer Lens
contact lens
etafilcon A Lens
contact lens
etafilcon A Lens
Participants were randomized to wear the etafilcon A lens pair for one week during the cross over study.
Hema-copolymer Lens
contact lens
etafilcon A Lens
contact lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hema-copolymer Lens
contact lens
etafilcon A Lens
contact lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* They are 18 years of age and above.
* They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
* They are willing and able to follow the protocol.
* They agree not to participate in other clinical research for the duration of this study.
* They can attain at least 6/9 in each eye with the study lenses within the available power range.
* They can be fitted with study lenses within the available power range.
* The currently use soft contact lenses, or have done so within the last six months.
Exclusion Criteria
* They have an ocular disorder which would normally contraindicate contact lens wear.
* They have a systemic disorder which would normally contraindicate contact lens wear.
* They are using any topical medication such as eye drops or ointment.
* They have had cataract surgery.
* They have had corneal refractive surgery.
* They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
* They are pregnant or lactating.
* They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
* They have any infectious disease which would normally contraindicate contact lens wear, or may, in the opinion of the investigator, pose a risk to study personnel; or any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reactions.
* They have taken part in any other clinical trial or research, within two weeks prior to starting this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CooperVision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carole Maldonado-Codinal, PhD
Role: PRINCIPAL_INVESTIGATOR
Eurolens Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eurolens Research - The University of Manchester
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CV13-545
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.